More bad news for the medical-technology “unicorn.”
Another day, another snag for Theranos, the blood-testing startup with a $10 billion valuation.
Health Insurer Orders Theranos To Stop Drawing Patients’ Blood
Willoughby Avenue is a digital publisher and an independent agency with over twenty years of experience. We create branding, communication and memorable experiences for Brands of Color.
About Us
Culture
Art
Politics
History
Race
Community
Faith
